Healthy volunteers test new drug VRG50635 for safety
NCT ID NCT06286475
First seen Dec 16, 2025 · Last updated May 23, 2026 · Updated 21 times
Summary
This early-stage study tested a new drug called VRG50635 in 22 healthy adults aged 19 to 55. The main goals were to see if the drug is safe and how the body absorbs it. Participants took the drug and were monitored for side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Lincoln Celerion Inc.,
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.